Plain-English translation of NCT07640191 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a medical device called the iVEAcare Neuromodulation System, which is implanted under the skin to help control seizures. The device works by stimulating a nerve in your neck to reduce how often and how severe your seizures are. Researchers want to see if this treatment is safe and whether it actually helps people whose seizures haven't gotten better with medications alone.
Many people with epilepsy continue to have seizures even after trying multiple anti-seizure medications. This trial exists to offer a new option—a device-based treatment—for people who haven't had success controlling their seizures through medication alone.
You likely qualify if…
You likely don't qualify if…
You will undergo surgery to have the iVEAcare device implanted under your skin. After surgery, you'll visit the clinic at 1 month, 3 months, 6 months, 1 year, 18 months, and then yearly through 5 years to answer questions about your seizures and quality of life. Between visits, you'll keep a daily diary of your seizures so researchers can track whether the treatment is working and whether you're experiencing any side effects.
AI-generated summary from trial data · Jul 22, 2026 · Not medical advice
Australia